Anchyra Partners
WST icon

Anchyra Partners’s West Pharmaceutical WST Stock Holding History

Anchyra Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$848K Buy
2,288
+31
+1% +$10.9K 0.18% 106
2026
Q2 		$810K Buy
2,257
+33
+1% +$10.1K 0.19% 99
2026
Q1 		$557K Buy
2,224
+5
+0.2% +$1.24K 0.17% 122
2025
Q4 		$611K Buy
+2,219
New +$607K 0.19% 106

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Anchyra Partners's WST Position: Q3 2026 in Review

Anchyra Partners increased its West Pharmaceutical (WST) stake by 1.4% in Q3 2026, buying an estimated $10.9K and bringing the position to 2,288 shares worth $848K. The position accounts for 0.18% of the portfolio, ranked #106.

Anchyra Partners first reported a position in WST in Q4 2025 and has held it in 4 quarters since. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Anchyra Partners held 2,288 shares of West Pharmaceutical worth $848K as of Q3 2026.
  • Anchyra Partners bought 31 West Pharmaceutical shares in Q3 2026, an estimated $10.9K.
  • West Pharmaceutical made up 0.18% of Anchyra Partners's portfolio in Q3 2026, its #106 holding.
  • Anchyra Partners first reported a position in West Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.